Society of Thoracic Surgeons Appoints New CEO
The Society of Thoracic Surgeons (STS) appointed Justine Varieur Turco as its CEO and executive director, effective August 31, 2026.
The Society of Thoracic Surgeons (STS) appointed Justine Varieur Turco as its CEO and executive director, effective August 31, 2026.
Risk-based models may improve screening efficiency compared to current guidelines, but accuracy issues remain for specific racial and ethnic populations.
Research indicates that healthy lifestyle habits can repress the inflammatory effects of age-related genetic mutations in white blood cells.
Phase 3 trial results show ralinepag significantly reduced the risk of worsening symptoms and improved exercise capacity in pulmonary arterial hypertension patients.
A study of more than 32,000 CTPA scans found that artificial intelligence and physicians agreed on pulmonary embolism results nearly 98% of the time, though human review caught cases the software missed.
Implementing specific protocols for older surgical patients can reduce complications such as delirium, falls, and pneumonia.
Researchers have developed a new form of CRISPR technology that destroys harmful cells instead of editing their genes, while leaving healthy tissue untouched.